TERT and cancer: Appreciating the existing limitations on functional research without TERT ASV-specific antibodies, it is still imperative to elucidate these possibly cancer-specific extra-telomeric functions so that therapeutic strategies to manipulate splicing away from FL-TERT can be developed, without realizing unintended adverse effects.